Patent · US Active

Beta-lactamase inhibitors

US9637504B2 · kind B2 · utility

17Cited by

6References

18Claims

0Family size

Assignee

VENATORX PHARMACEUTICALS, INC. · US

Inventors

Christopher J. Burns · Vivonne Bay, AU
Denis DAIGLE · Street, US
Bin Liu · Fishers, US
Randy W. Jackson · Livingston, US
Jodie HAMRICK · New Holland, US
Daniel McGarry · King of Prussia, US
Daniel C. Pevear · Downingtown, US
Robert E. Lee TROUT · Collegeville, US

Key dates

Filing date	May 23, 2016
Grant date	May 2, 2017
Priority date	—
Expiry date	May 23, 2036

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described herein are compounds and compositions that modulate the activity of beta-lactamases. In some embodiments, the compounds described herein inhibit beta-lactamase. In certain embodiments, the compounds described herein are useful in the treatment of bacterial infections.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.